SINGAPORE,First and only chemotherapy-free combination in the first-line setting to demonstrate an overall survival benefit versus osimertinib among Asian patients.

Ovarian cancer tends to be resistant to hormone therapy, even when it should theoretically respond. Wistar Institute ...

Researchers have characterised the structure and function of a key protein that helps breast cancer cells survive.

Researchers used CRISPR screening in tumor organoids and mice to identify two genes, Ctnna1 and Bcl2l13, that suppress ...

A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

Poster outlines clinical benefit with acceptable safety profile across 9 tested dosing regimensAccelerated step-up dosing and higher dosing frequency is feasible and results in increased exposure Six ...

Dispersing federal research funding, largely concentrated at private universities on the coasts, to the rest of the country ...

A team of scientists at the University of California, Los Angeles (UCLA) have developed a groundbreaking cell-based ...

After facing a first cancer, we always hope the worst is behind us. However, for people with glioblastoma, a very aggressive ...

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...